Different Dose Esketamine and Dexmedetomidine Combination for Supplemental Analgesia After Scoliosis Correction Surgery

Clinical trial NCT06062550 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06062550
Sponsor: Peking University First Hospital
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Scoliosis Correction Esketamine Dexmedetomidine Postoperative Analgesia Chronic Postsurgical Pain

Start date: 2023-10-24
Primary completion: 2025-10-23
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.